{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:42:22Z","timestamp":1779356542456,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejso.2025.110361","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:25:43Z","timestamp":1754367943000},"page":"110361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study"],"prefix":"10.1016","volume":"51","author":[{"given":"Dongxu","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-4108","authenticated-orcid":false,"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkang","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-3600","authenticated-orcid":false,"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanqing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-4562","authenticated-orcid":false,"given":"Xinfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingda","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-0698","authenticated-orcid":false,"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110361_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.110361_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib4","article-title":"Hepatocellular carcinoma in China","volume":"340","author":"Yang","year":"2010","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.ejso.2025.110361_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2017.05.029","article-title":"How to predict global trends in HCC mortality if neglecting more than half the world's cases","volume":"67","author":"Sun","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib6","article-title":"Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in China","author":"Cai","year":"20253139","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100083","article-title":"Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma","volume":"3","author":"Wang","year":"2024","journal-title":"iLIVER"},{"key":"10.1016\/j.ejso.2025.110361_bib8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/SLA.0000000000002889","article-title":"Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma","volume":"268","author":"Pinna","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.110361_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.21037\/hbsn-21-288","article-title":"Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study","volume":"12","author":"Yan","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.ejso.2025.110361_bib10","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1634\/theoncologist.2019-0944","article-title":"Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ejso.2025.110361_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.surg.2024.03.028","article-title":"Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate\/advanced (BCLC stage B\/C) hepatocellular carcinoma","volume":"176","author":"Diao","year":"2024","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110361_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100008","article-title":"Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma","volume":"1","author":"Chen","year":"2023","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ejso.2025.110361_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100110","article-title":"Optimising postoperative surveillance for hepatocellular carcinoma: beyond histological predictors","volume":"3","author":"Xu","year":"2024","journal-title":"iLIVER"},{"key":"10.1016\/j.ejso.2025.110361_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","article-title":"Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China","volume":"154","author":"Xu","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2025.110361_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002870","article-title":"Comment on \"Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: validation of a Clinical Risk Score in Aninternational Cohort\"","volume":"269","author":"Yu","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.110361_bib16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.surg.2022.05.023","article-title":"Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0\/A hepatocellular carcinoma: a large-scale multicenter study","volume":"172","author":"Feng","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110361_bib17","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1245\/s10434-022-11454-y","article-title":"Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi-institutional analysis","volume":"29","author":"Yao","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110361_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.hpb.2019.09.006","article-title":"Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study","volume":"22","author":"Xing","year":"2020","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejso.2025.110361_bib19","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1245\/s10434-023-14721-8","article-title":"Surgical decision-making considerations in hepatocellular carcinoma resection: safety and efficacy","volume":"31","author":"Tang","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110361_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2025.110361_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejso.2011.03.137","article-title":"Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade","volume":"37","author":"Zhou","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110361_bib23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00261-017-1072-0","article-title":"CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma","volume":"42","author":"Zhou","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ejso.2025.110361_bib24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1373\/clinchem.2019.308965","article-title":"A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B","volume":"65","author":"Yang","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejso.2025.110361_bib25","article-title":"ASAP score versus GALAD score for detection of hepatitis C-related hepatocellular carcinoma: a multicenter case-control analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.110361_bib26","article-title":"Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score","author":"Sun","year":"202524412","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ejso.2025.110361_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100098","article-title":"Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"3","author":"Ouyang","year":"2024","journal-title":"iLIVER"},{"key":"10.1016\/j.ejso.2025.110361_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrab145","article-title":"Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: Multicentre propensity score-matching study","volume":"6","author":"Pu","year":"2022","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2025.110361_bib29","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.hpb.2019.12.006","article-title":"Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma","volume":"22","author":"Xing","year":"2020","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejso.2025.110361_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.surg.2018.08.031","article-title":"Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: a multicenter study","volume":"165","author":"Zhang","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110361_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2002.tb04092.x","article-title":"Hepatocellular carcinoma: role of estrogen receptors in the liver","volume":"963","author":"Villa","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejso.2025.110361_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1245\/s10434-023-14525-w","article-title":"Prognostic value of serum \u03b1-Fetoprotein level as an important characteristic of tumor biology for patients undergoing liver resection of early-stage hepatocellular carcinoma (BCLC stage 0\/A): a large multicenter analysis","volume":"31","author":"Yao","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110361_bib33","article-title":"Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients","author":"Wang","year":"2024291723","journal-title":"Oncologist"},{"key":"10.1016\/j.ejso.2025.110361_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/JHC.S289840","article-title":"Association of postoperative biomarker response with recurrence and survival in patients with hepatocellular carcinoma and high alpha-fetoprotein expressions (>400 Ng\/Ml)","volume":"8","author":"Liang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.ejso.2025.110361_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3350\/cmh.2022.0212","article-title":"Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region","volume":"29","author":"Kim","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2025.110361_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2024.01.010","article-title":"Merits and boundaries of the BCLC staging and treatment algorithm: learning from the past to improve the future with a novel proposal","volume":"80","author":"Trevisani","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib39","doi-asserted-by":"crossref","first-page":"15447","DOI":"10.1007\/s13277-016-5443-x","article-title":"Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma","volume":"37","author":"Xing","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejso.2025.110361_bib40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2015.04.031","article-title":"PIVKA-II is an independent prognostic factor for overall survival of HCC patients and maybe associated with epithelial-mesenchymal transition","volume":"63","author":"Xu","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2014.11.005","article-title":"Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion","volume":"62","author":"Pot\u00e9","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1542-3565(05)00855-4","article-title":"Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma","volume":"4","author":"Toyoda","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/lt.24117","article-title":"Combinations of biomarkers and milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation","volume":"21","author":"Chaiteerakij","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ejso.2025.110361_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrgastro.2015.173","article-title":"Immunological landscape and immunotherapy of hepatocellular carcinoma","volume":"12","author":"Prieto","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2025.110361_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejso.2025.110361_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3350\/cmh.2023.0106","article-title":"Management of hepatocellular carcinoma in China: seeking common grounds while reserving differences","volume":"29","author":"Yang","year":"2023","journal-title":"Clin Mol Hepatol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325007899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325007899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:39:40Z","timestamp":1759001980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325007899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0748798325007899"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110361","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110361"}}